COVID-19

ICMR intensifies efforts to enhance availability of COVID testing kits, newer innovative testing solutions.

The Indian Council of Medical Research has intensified its efforts to enhance availability of COVID-19 testing kits and newer innovative testing solutions amid the rising cases of coronavirus in India.
 
ICMR has proposed to exempt several reputed global agencies from validation criteria for RTPCR, RAT, home based testing solution, antigen, antibody ELISA and rapid antibody tests. It further proposed to accord marketing permission by Drugs Controller General of India on the basis of existing approvals.
 
Several global agencies of Europe, Japan, South Korea, Australia, Brazil and the agencies listed in the World Health Organization’s emergency use listing will benefit from this move.
 
At present, kits approved by the US Food and Drug Administration under regular or emergency use are exempted from validation in India. It qualifies for direct marketing permission from the Drug Controller General of India.

Click to comment

Leave a Reply

Your email address will not be published.

4 × 1 =

News is information about current events. News is provided through many different media: word of mouth, printing, postal systems, broadcasting, electronic communication, and also on the testimony of observers and witnesses to events. It is also used as a platform to manufacture opinion for the population.

Contact Info

Address:
D 601  Riddhi Sidhi CHSL
Unnant Nagar Road 2
Kamaraj Nagar, Goreagaon West
Mumbai 400062 .

Email Id: [email protected]

West Bengal

Eastern Regional Office
Indsamachar Digital Media
Siddha Gibson 1,
Gibson Lane, 1st floor, R. No. 114,
Kolkata – 700069.
West Bengal.

Office Address

251 B-Wing,First Floor,
Orchard Corporate Park, Royal Palms,
Arey Road, Goreagon East,
Mumbai – 400065.

Download Our Mobile App

IndSamachar Android App IndSamachar IOS App
To Top
WhatsApp WhatsApp us